Kidney function decline improves after lithium discontinuation
Journal of Internal Medicine · 2025-03 · 297 (3) · 289-299
DOI: 10.1111/joim.20054 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Internal Medicine, online erschienen am 20.01.2025. Verfasst von Filip Fransson und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden. Hauptthemen laut MEDLINE: Glomerular Filtration Rate, Lithium Compounds, Kidney, Withholding Treatment. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Norrbotten and Västerbotten Regional Research and Learning Funds, VISARE NORR (Northern County Councils Regional Federation Fund), Svensk Njurmedicinsk Förening.
Abstract (Originalsprache)
Background
Long‐term lithium treatment decreases kidney function. However, it remains unclear whether stopping lithium improves kidney function.
Objectives
To study kidney function in patients who stopped and subsequently restarted lithium treatment.
Methods
Mirror‐image design using data from the LiSIE retrospective cohort study. The mirror was set to when lithium was stopped with a 5‐year pre‐ and post‐mirror period. Adult patients with bipolar, schizoaffective disorder or unipolar depression, who had lithium ≥4.5 years in the pre‐mirror period, were included. Creatinine measurements were available from 1997 to 2017. The main outcome was the difference in mean annual change of the estimated glomerular filtration rate (eGFR) adjusted for sex, hypertension and diabetes mellitus.
Results
A total of 168 participants (94 women, 74 men) were included. Mean annual eGFR change was −1.58 (−1.87 to −1.28) mL/min/1.73 m 2 /year before and −0.023 (−0.49 to +0.44) mL/min/1.73 m 2 /year after lithium discontinuation ( p < 0.0001 for difference). The improvement was 0.77 (0.35–1.20) mL/min/173 m 2 /year in participants with eGFR >60 mL/min/1.73 m 2 , and 3.03 (2.15–3.92) mL/min/1.73 m 2 /year for participants with eGFR
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
- Department of Clinical Sciences, Psychiatry, Sunderby Research Unit, Umeå University, Umeå, Sweden.
ORCID-Profile: Filip Fransson, Ursula Werneke, Louise Öhlund, P Andreas Jonsson, Michael Ott
Förderung
- Norrbotten and Västerbotten Regional Research and Learning Funds
- VISARE NORR (Northern County Councils Regional Federation Fund)
- Svensk Njurmedicinsk Förening
- The Swedish Kidney Association (Njurförbundet), Norrbotten section
- Arnerska research fund
- Njurfonden
- The Västerbotten regional agreement on medical training and clinical research (ALF) -fund
- Medicinska fakulteten, Umeå Universitet
Zitieren
APA
Fransson, F., Werneke, U., Öhlund, L., Jonsson, P. A., & Ott, M. (2025). Kidney function decline improves after lithium discontinuation. Journal of Internal Medicine, 297(3), 289-299. https://doi.org/10.1111/joim.20054
Vancouver
Fransson F, Werneke U, Öhlund L, Jonsson PA, Ott M. Kidney function decline improves after lithium discontinuation. Journal of Internal Medicine. 2025;297(3):289-299. doi:10.1111/joim.20054
BibTeX
@article{Fransson2025,
author = {Fransson, Filip and Werneke, Ursula and Öhlund, Louise and Jonsson, P Andreas and Ott, Michael},
title = {Kidney function decline improves after lithium discontinuation},
journal = {Journal of Internal Medicine},
year = {2025},
volume = {297},
number = {3},
pages = {289--299},
doi = {10.1111/joim.20054}
}
EUVIMED